These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6782910

  • 1. Biotransformation of sevoflurane in dogs and rats.
    Martis L, Lynch S, Napoli MD, Woods EF.
    Anesth Analg; 1981 Apr; 60(4):186-91. PubMed ID: 6782910
    [Abstract] [Full Text] [Related]

  • 2. Renal safety and extrahepatic defluorination of sevoflurane in hepatic transplantations.
    Kanbak M, Karagoz AH, Erdem N, Oc B, Saricaoglu F, Ertas N, Berkkan A, Abbasoglu O, Aypar U.
    Transplant Proc; 2007 Jun; 39(5):1544-8. PubMed ID: 17580185
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of phenytoin (DPH) treatment on methoxyflurane metabolism in rats.
    Caughey GH, Rice SA, Kosek JC, Mazze RI.
    J Pharmacol Exp Ther; 1979 Aug; 210(2):180-5. PubMed ID: 458627
    [Abstract] [Full Text] [Related]

  • 6. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers.
    Holaday DA, Smith FR.
    Anesthesiology; 1981 Feb; 54(2):100-6. PubMed ID: 6781380
    [Abstract] [Full Text] [Related]

  • 7. P450-dependent and nonenzymatic human liver microsomal defluorination of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), a sevoflurane degradation product.
    Kharasch ED, Hankins DC.
    Drug Metab Dispos; 1996 Jun; 24(6):649-54. PubMed ID: 8781780
    [Abstract] [Full Text] [Related]

  • 8. Cardiorespiratory effects of low-flow and closed circuit inhalation anesthesia, using sevoflurane delivered with an in-circuit vaporizer and concentrations of compound A.
    Muir WW, Gadawski J.
    Am J Vet Res; 1998 May; 59(5):603-8. PubMed ID: 9582964
    [Abstract] [Full Text] [Related]

  • 9. Renal function after sevoflurane or enflurane anesthesia in the Fischer 344 rat.
    Malan TP, Kadota Y, Mata H, Frink EJ, Brown BR.
    Anesth Analg; 1993 Oct; 77(4):817-21. PubMed ID: 8214671
    [Abstract] [Full Text] [Related]

  • 10. I-653 resists degradation in rats.
    Koblin DD, Eger EI, Johnson BH, Konopka K, Waskell L.
    Anesth Analg; 1988 Jun; 67(6):534-8. PubMed ID: 3377207
    [Abstract] [Full Text] [Related]

  • 11. Serum and urine inorganic fluoride concentrations and urine oxalate concentrations following methoxyflurane anesthesia in the dog.
    Brunson DB, Stowe CM, McGrath CJ.
    Am J Vet Res; 1979 Feb; 40(2):197-203. PubMed ID: 464357
    [Abstract] [Full Text] [Related]

  • 12. Comparison of plasma inorganic fluoride concentration with sevoflurane-N2O and enflurane-N2O anesthesia.
    Min KT, Shin YS, Kim JR, Choi MY, Hong JY.
    Yonsei Med J; 1994 Jun; 35(2):218-22. PubMed ID: 8091799
    [Abstract] [Full Text] [Related]

  • 13. Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation.
    Kharasch ED, Armstrong AS, Gunn K, Artru A, Cox K, Karol MD.
    Anesthesiology; 1995 Jun; 82(6):1379-88. PubMed ID: 7793652
    [Abstract] [Full Text] [Related]

  • 14. Renal effects and metabolism of sevoflurane in Fisher 3444 rats: an in-vivo and in-vitro comparison with methoxyflurane.
    Cook TL, Beppu WJ, Hitt BA, Kosek JC, Mazze RI.
    Anesthesiology; 1975 Jul; 43(1):70-7. PubMed ID: 1147310
    [Abstract] [Full Text] [Related]

  • 15. Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function.
    Frink EJ, Ghantous H, Malan TP, Morgan S, Fernando J, Gandolfi AJ, Brown BR.
    Anesth Analg; 1992 Feb; 74(2):231-5. PubMed ID: 1731542
    [Abstract] [Full Text] [Related]

  • 16. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A).
    Iyer RA, Anders MW.
    Chem Res Toxicol; 1997 Jul; 10(7):811-9. PubMed ID: 9250416
    [Abstract] [Full Text] [Related]

  • 17. Biotransformation of sevoflurane.
    Kharasch ED.
    Anesth Analg; 1995 Dec; 81(6 Suppl):S27-38. PubMed ID: 7486145
    [Abstract] [Full Text] [Related]

  • 18. Evidence for metabolism of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), a sevoflurane degradation product, by cysteine conjugate beta-lyase.
    Spracklin DK, Kharasch ED.
    Chem Res Toxicol; 1996 Jun; 9(4):696-702. PubMed ID: 8831812
    [Abstract] [Full Text] [Related]

  • 19. Sevoflurane: an experimental anesthetic.
    Holaday DA.
    Contemp Anesth Pract; 1983 Jun; 7():45-59. PubMed ID: 6884031
    [Abstract] [Full Text] [Related]

  • 20. Biotransformation of sevoflurane by rat neonate liver slices.
    Payne AK, Morgan SE, Gandolfi AJ, Brendel K.
    Drug Metab Dispos; 1995 Apr; 23(4):497-500. PubMed ID: 7600918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.